Reports
Sale
Global Cardiovascular Stents Market Size, Share, Forecast: By Procedure Type: Coronary Stenting, Peripheral Stenting; By Stent Type: Drug Eluting Stents (DES), Bioresorbable Stents, Bare Metal Stents, Dual Therapy Stent, Others; By Material; By Disease Indication; By End-User; Regional Analysis; Competitive Landscape; 2024-2032
Global Cardiovascular Stents Market Outlook
The global cardiovascular stents market reached a value of about USD 14.06 billion in 2023. The industry is further expected to grow at a CAGR of about 4.80% in the forecast period of 2024-2032 to reach a value of around USD 21.44 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to be a Significant Regional Market for Cardiovascular Stents
North America dominates the market for cardiovascular stents due to the growing prevalence. An improving level of healthcare infrastructure, coupled with the increased research and development proficiencies, has fostered the development of the industry in this region. A sedentary lifestyle results in obesity and other cardiovascular diseases, such as heart attack, stroke, and ischemic heart diseases (IHD), primarily driving the market growth in North America. In addition, various technological advancements in cardiovascular stent technologies, such as bifurcated stents and biodegradable materials, have further aided the market growth.
The Asia Pacific region, on the contrary, will exhibit the highest growth rate during the forecast period due to the rise in angioplasty surgeries in this region. Rising diabetic patients and bad lifestyle choices, such as drinking and smoking, have bolstered the market growth. The market is driven by the rising ageing population with cardiovascular disease, improving healthcare infrastructure in developing economies, rising PCI procedures, growing healthcare awareness, improved reimbursement scenario, and low manufacturing cost of coronary stents in this region.
Market Segmentations
In order to reopen a blocked or narrowed coronary artery, a cardiovascular stent is used. These stents are also utilised to help the heart's blood flow. It also lowers the chance of a heart attack or heat stroke, enhancing a person's quality of life.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on procedure type, the market includes:
- Coronary Stenting
- Peripheral Stenting
By stent type, the market is segmented into:
- Drug-Eluting Stents (DES)
- Bioresorbable Stents
- Bare Metal Stents
- Dual Therapy Stent
- Others
The various materials in the market are:
- Stainless Steel
- Cobalt-Chromium
- Nitinol
- Polymers
Based on disease indication, the market is divided into:
- Venous Diseases
- Arterial Diseases
The end-users of the market are:
- Hospitals
- Ambulatory Surgery Centres
- Speciality Clinics
- Catheterisation Labs
The regional markets for the cardiovascular stents industry can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Prevalence of Cardiovascular Diseases Augmenting the Market Growth
The rising prevalence of cardiovascular diseases (CVDs), like stroke and heart attack, and the rising geriatric population at higher risk of cardiac diseases are expected to propel the demand for cardiovascular stents over the forecast period. The low rate of risks involved, and the low cost of manufacturing have also pushed the demand for cardiovascular stents. Another factor projected to drive the utilisation of cardiovascular stents throughout the forecast period is the growing preference for minimally invasive surgeries (MIS). These procedures have the advantage of having tiny incision wounds, which leads to increased patient satisfaction. These procedures also result in shorter hospital stays and faster recovery times. Technological advances in cardiovascular stents, such as the invention of bifurcation stents and biodegradable materials, have led to more effective and improved CVD treatment outcomes. Companies are actively involved in product developments, partnerships, and strategic collaborations. The factors mentioned are likely to boost the market for cardiovascular stents forward in the coming years. Additionally, an increase in funding from private and government organisations for the development of the healthcare sector and research centres; and a rise in demand for drug-eluting stents are also expected to propel the market growth globally.
Key Players in the Global Cardiovascular Stents Market
The report gives a detailed analysis of the following key players in the global cardiovascular stents industry, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Cordis US Corp
- BIOTRONIK SE & Co KG
- MicroPort Scientific Corporation
- Abbott Laboratories
- Boston Scientific Corporation (BSC)
- Medtronic Plc
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Procedure Type |
|
| Breakup by Stent Type |
|
| Breakup by Material |
|
| Breakup by Disease Indication |
|
| Breakup by End-User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Region
7 Opportunities and Challenges in the Market
8 Global Cardiovascular Stents Market Analysis
8.1 Key Industry Highlights
8.2 Global Cardiovascular Stents Historical Market (2018-2023)
8.3 Global Cardiovascular Stents Market Forecast (2024-2032)
8.4 Global Cardiovascular Stents Market by Procedure Type
8.4.1 Coronary Stenting
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Peripheral Stenting
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.5 Global Cardiovascular Stents Market by Stent Type
8.5.1 Drug Eluting Stents (DES)
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Bioresorbable Stents
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Bare Metal Stents
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Dual Therapy Stent
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Others
8.6 Global Cardiovascular Stents Market by Material
8.6.1 Stainless Steel
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Cobalt Chromium
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Nitinol
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Polymers
8.6.4.1 Historical Trend (2018-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.7 Global Cardiovascular Stents Market by Disease Indication
8.7.1 Venous Diseases
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Arterial Diseases
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.8 Global Cardiovascular Stents Market by End-User
8.8.1 Hospitals
8.8.1.1 Historical Trend (2018-2023)
8.8.1.2 Forecast Trend (2024-2032)
8.8.2 Ambulatory Surgery Centres
8.8.2.1 Historical Trend (2018-2023)
8.8.2.2 Forecast Trend (2024-2032)
8.8.3 Speciality Clinics
8.8.3.1 Historical Trend (2018-2023)
8.8.3.2 Forecast Trend (2024-2032)
8.8.4 Catheterisation Labs
8.8.4.1 Historical Trend (2018-2023)
8.8.4.2 Forecast Trend (2024-2032)
8.9 Global Cardiovascular Stents Market by Region
8.9.1 North America
8.9.1.1 Historical Trend (2018-2023)
8.9.1.2 Forecast Trend (2024-2032)
8.9.2 Europe
8.9.2.1 Historical Trend (2018-2023)
8.9.2.2 Forecast Trend (2024-2032)
8.9.3 Asia Pacific
8.9.3.1 Historical Trend (2018-2023)
8.9.3.2 Forecast Trend (2024-2032)
8.9.4 Latin America
8.9.4.1 Historical Trend (2018-2023)
8.9.4.2 Forecast Trend (2024-2032)
8.9.5 Middle East and Africa
8.9.5.1 Historical Trend (2018-2023)
8.9.5.2 Forecast Trend (2024-2032)
9 North America Cardiovascular Stents Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Cardiovascular Stents Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Cardiovascular Stents Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Cardiovascular Stents Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Cardiovascular Stents Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Cordis US Corp
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 BIOTRONIK SE & Co KG
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 MicroPort Scientific Corporation
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Abbott Laboratories
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.3.4 Certifications
16.2.5 Boston Scientific Corporation (BSC)
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Medtronic Plc
16.2.6.1 Company Overview
16.2.6.2 Product Portfolio
16.2.6.3 Demographic Reach and Achievements
16.2.6.4 Certifications
16.2.7 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Cardiovascular Stents Market: Key Industry Highlights, 2018 and 2032
2. Global Cardiovascular Stents Historical Market: Breakup by Procedure Type (USD Billion), 2018-2023
3. Global Cardiovascular Stents Market Forecast: Breakup by Procedure Type (USD Billion), 2024-2032
4. Global Cardiovascular Stents Historical Market: Breakup by Stent Type (USD Billion), 2018-2023
5. Global Cardiovascular Stents Market Forecast: Breakup by Stent Type (USD Billion), 2024-2032
6. Global Cardiovascular Stents Historical Market: Breakup by Material (USD Billion), 2018-2023
7. Global Cardiovascular Stents Market Forecast: Breakup by Material (USD Billion), 2024-2032
8. Global Cardiovascular Stents Historical Market: Breakup by Disease Indication (USD Billion), 2018-2023
9. Global Cardiovascular Stents Market Forecast: Breakup by Disease Indication (USD Billion), 2024-2032
10. Global Cardiovascular Stents Historical Market: Breakup by End-User (USD Billion), 2018-2023
11. Global Cardiovascular Stents Market Forecast: Breakup by End-User (USD Billion), 2024-2032
12. Global Cardiovascular Stents Historical Market: Breakup by Region (USD Billion), 2018-2023
13. Global Cardiovascular Stents Market Forecast: Breakup by Region (USD Billion), 2024-2032
14. North America Cardiovascular Stents Historical Market: Breakup by Country (USD Billion), 2018-2023
15. North America Cardiovascular Stents Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Europe Cardiovascular Stents Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Europe Cardiovascular Stents Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Asia Pacific Cardiovascular Stents Historical Market: Breakup by Country (USD Billion), 2018-2023
19. Asia Pacific Cardiovascular Stents Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Latin America Cardiovascular Stents Historical Market: Breakup by Country (USD Billion), 2018-2023
21. Latin America Cardiovascular Stents Market Forecast: Breakup by Country (USD Billion), 2024-2032
22. Middle East and Africa Cardiovascular Stents Historical Market: Breakup by Country (USD Billion), 2018-2023
23. Middle East and Africa Cardiovascular Stents Market Forecast: Breakup by Country (USD Billion), 2024-2032
24. Global Cardiovascular Stents Market Structure.
Key Questions Answered in the Report
In 2023, the global cardiovascular stents market attained a value of nearly USD 14.06 billion.
The market is projected to grow at a CAGR of 4.80% between 2024 and 2032.
The market is estimated to witness healthy growth in the forecast period of 2024-2032 to reach USD 21.44 billion by 2032.
The major drivers of the market include the increased research and development activities, rising angioplasty surgeries, rising diabetic patients, growing healthcare awareness, low cost of manufacturing, increasing preference for minimally invasive surgeries (MIS), technological advances, increase in funding from private and government organisations, and a rise in demand for drug-eluting stents.
The rising prevalence of cardiovascular diseases (CVDs) and the growing geriatric population are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Based on procedure type, the market includes coronary stenting and peripheral stenting.
The major stent types are drug-eluting stents (DES), bioresorbable stents, bare-metal stents, and dual therapy stents.
The various materials in the market are stainless steel, cobalt-chromium, nitinol, and polymers.
The market is divided into venous and arterial diseases based on disease indication.
The end-users of the market are hospitals, ambulatory surgery centres, speciality clinics, and catheterisation labs.
The major players in the industry are Cordis US Corp, BIOTRONIK SE & Co KG, MicroPort Scientific Corporation, Abbott Laboratories, Boston Scientific Corporation (BSC), and Medtronic Plc, among others.
Analyst Review
The global cardiovascular stents market attained a value of USD 14.06 billion in 2023, driven by the increasing prevalence of cardiovascular diseases (CVDs). Aided by the growing healthcare awareness and geriatric population, the market is expected to witness further growth in the forecast period of 2024-2032, growing at a CAGR of 4.80%. The market is projected to reach USD 21.44 billion by 2032.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on procedure type, the market includes coronary stenting and peripheral stenting. The major stent types are drug-eluting stents (DES), bioresorbable stents, bare-metal stents, and dual therapy stents, among others. The various materials in the market are stainless steel, cobalt-chromium, nitinol, and polymers. Based on disease indication, the market is divided into venous diseases and arterial diseases. The end-users of the market are hospitals, ambulatory surgery centres, speciality clinics, and catheterisation labs. The major regional markets for cardiovascular stents are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The key players in the cardiovascular stents market are Cordis US Corp, BIOTRONIK SE & Co KG, MicroPort Scientific Corporation, Abbott Laboratories, Boston Scientific Corporation (BSC), and Medtronic Plc, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER